NASDAQ:BYSI
BeyondSpring Inc Stock News
$2.28
+0.0300 (+1.33%)
At Close: May 06, 2024
BeyondSpring and Leading Cancer Center to Present Poster at SITC's 38th Annual Meeting
10:00am, Wednesday, 27'th Sep 2023
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbrea
BeyondSpring to Participate in the R.W. Baird's 2023 Global Healthcare Conference
08:00am, Thursday, 07'th Sep 2023
NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbrea
BeyondSpring and Leading Cancer Center to Present Poster at 2023 ASCO Annual Meeting
08:30am, Thursday, 18'th May 2023
NEW YORK, May 18, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaki
Penny Stocks To Buy? 4 To Watch Before Next Week
01:40pm, Thursday, 15'th Dec 2022
Hot penny stocks to watch this week. The post Penny Stocks To Buy?
BeyondSpring, Inc. (BYSI) Q4 2021 Earnings Call Transcript
05:30pm, Thursday, 14'th Apr 2022 The Motley Fool
BYSI earnings call for the period ending March 31, 2022.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Pfizer-BioNTech's COVID-19 Vaccine Booster Shows High Immune Response In Kids Ages 5-11
Pfizer Inc (
BeyondSpring Inc. (BYSI) CEO Lan Huang on Q4 2021 Results - Earnings Call Transcript
01:06pm, Thursday, 14'th Apr 2022
BeyondSpring Inc. (NASDAQ:BYSI ) Q4 2022 Earnings Conference Call April 14, 2022 8:00 AM ET Company Participants Ashley Sierchio - LifeSci Advisors Lan Huang - Co-Founder, Chairman and CEO Ramon Mohan
BeyondSpring Files 2021 Annual Report on Form 20-F
01:04pm, Thursday, 14'th Apr 2022 GlobeNewswire Inc.
NEW YORK, April 14, 2022 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a clinical stage global biopharmaceutical company focused on developing innov
BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update
11:00am, Thursday, 14'th Apr 2022 GlobeNewswire Inc.
- Company to host call today, April 14, 2022 at 8:00 am ET
BeyondSpring to Announce Fourth Quarter and Year End 2021 Financial Results and Host a Conference Call on Thursday, April 14, 2022
12:00pm, Friday, 08'th Apr 2022 GlobeNewswire Inc.
NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative c
NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative can
BeyondSpring Inc.s (BYSI) Volatility Reaches 6.26%: Dont Be Comfortable
03:00pm, Saturday, 12'th Feb 2022 Stocks Register
BeyondSpring Inc. (NASDAQ:BYSI) price on Friday, February 11, fall -4.81% below its previous days close as a downside momentum from buyers pushed the stocks value to $2.97. A look at the stocks price movement, the close in the last trading session was $3.12, moving within a range at $2.945 and $3.145. The beta value (5-Year BeyondSpring Inc.s (BYSI) Volatility Reaches 6.26%: Dont Be Comfortable Read More »
BeyondSpring Inc. (NASDAQ:BYSI), 8.79% Above Its High, Could Make A Strong Comeback.
04:30pm, Saturday, 05'th Feb 2022 Marketing Sentinel
In last trading session, BeyondSpring Inc. (NASDAQ:BYSI) saw 0.32 million shares changing hands with its beta currently measuring 1.09. Company’s recent per share price level of $3.07 trading at $0.08 or 2.68% at ring of the bell on the day assigns it a market valuation of $113.01M. That closing price of BYSI’s stock is at … BeyondSpring Inc. (NASDAQ:BYSI), 8.79% Above Its High, Could Make A Strong Comeback. Read More »
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
01:30pm, Wednesday, 12'th Jan 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours.
Stocks In Focus
Biogen Shares Slip On Restricted Coverage For Its Alzheimer's Drug
Biogen, Inc. (NASDAQ: BIIB) shares